Seizures as treatment-emergent adverse events during glioblastoma clinical trials.

被引：0
|
作者：
Dillman, Robert O. [1 ]
机构：
[1] AIVITA Biomed, Irvine, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14018
引用
收藏
页数：1
相关论文
共 50 条
  • [31] EVOLUTION OF TREATMENT-EMERGENT RESISTANT VARIANTS IN TELAPREVIR PHASE 3 CLINICAL TRIALS
    Sullivan, J. C.
    De Meyer, S.
    Bartels, D. J.
    Dierynck, I.
    Zhang, E.
    Spanks, J.
    Tigges, A.
    Adda, N.
    Martin, E. C.
    Beumont, M.
    Jacobson, I. M.
    Sherman, K. E.
    Zeuzem, S.
    Picchio, G.
    Kieffer, T. L.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S4 - S4
  • [32] Evolution of Treatment-Emergent Resistant Variants in Telaprevir Phase 3 Clinical Trials
    Sullivan, James C.
    De Meyer, Sandra
    Bartels, Doug J.
    Dierynck, Inge
    Zhang, Eileen Z.
    Spanks, Joan
    Tigges, Ann M.
    Ghys, Anne
    Dorrian, Jennifer
    Adda, Nathalie
    Martin, Emily C.
    Beumont, Maria
    Jacobson, Ira M.
    Sherman, Kenneth E.
    Zeuzem, Stefan
    Picchio, Gaston
    Kieffer, Tara L.
    CLINICAL INFECTIOUS DISEASES, 2013, 57 (02) : 221 - 229
  • [33] Visual Hallucinations: A Treatment-Emergent Adverse Effect of Linezolid
    Palaniappan, Pradeep
    Rajaraman, Venkateswaran
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2015, 27 (01) : E65 - E65
  • [34] Comparison of misoprostol vaginal insert and dinoprostone vaginal insert: incidence of treatment-emergent adverse events
    Ehrenberg-Buchner, Stacey
    Wing, Deborah
    Brown, Raymond
    Plante, Lauren
    Rugarn, Olof
    Powers, Barbara
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2013, 208 (01) : S150 - S150
  • [35] Analysis of Psychiatric Treatment-Emergent Adverse Events (TEAEs) in Two Phase III Conversion-to-Eslicarbazepine Acetate (ESL) Monotherapy Trials
    Harden, Cynthia
    Salpekar, Jay
    Loring, David
    Grinnell, Todd
    Cantu, David
    Cheng, Hailong
    Blum, David
    NEUROLOGY, 2018, 90
  • [36] Detecting treatment emergent adverse events in clinical trials - A comparison of spontaneously reported and solicited collection methods
    Wernicke, JF
    Faries, D
    Milton, D
    Weyrauch, K
    DRUG SAFETY, 2005, 28 (11) : 1057 - 1063
  • [37] Factors Predictive of Treatment-Emergent Adverse Events of Prucalopride: An Integrated Analysis of Four Randomized Double-Blind, Placebo-Controlled Trials
    Leelakusolvong, Somchai
    Ke, MeiYun
    Zou, Duowu
    Choi, Suck Chei
    Tack, Jan
    Quigley, Eamonn M. M.
    Liu, Andy
    Kim, JinYong
    GUT AND LIVER, 2015, 9 (02) : 208 - 213
  • [38] Impact of adverse events on color change during vital bleaching: Meta-analysis of 6 clinical trials.
    Gerlach, RW
    Barker, ML
    JOURNAL OF DENTAL RESEARCH, 2002, 81 : A308 - A308
  • [39] Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials
    Lebwohl, Mark G.
    Papp, Kim A.
    Marangell, Lauren B.
    Koo, John
    Blauvelt, Andrew
    Gooderham, Melinda
    Wu, Jashin J.
    Rastogi, Shipra
    Harris, Susan
    Pillai, Radhakrishnan
    Israel, Robert J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (01) : 81 - +
  • [40] Treatment-emergent adverse events in dupilumab-treated patients with allergic diseases: A meta-analysis
    Chen, Xiaohong
    Liu, Menghui
    Wu, Shuo
    Huang, Zizhen
    Li, Xia
    Lai, Xiaoping
    Bao, Hongwei
    Huang, Jiancong
    Chang, Lihong
    Zhang, Gehua
    ALLERGY, 2021, 76 (02) : 593 - 596
12345